(SBS) Companhia de Saneamento - Overview
Sector: UtilitiesIndustry: Utilities - Regulated Water | Exchange NYSE (USA) | Currency USD | Market Cap: 20.357m | Total Return 78.1% in 12m
Stock: Water, Sewage, Sanitation
Total Rating 69
Risk 78
Buy Signal 0.33
| Risk 5d forecast | |
|---|---|
| Volatility | 36.3% |
| Relative Tail Risk | -1.17% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.78 |
| Alpha | 61.32 |
| Character TTM | |
|---|---|
| Beta | 0.627 |
| Beta Downside | 0.118 |
| Drawdowns 3y | |
|---|---|
| Max DD | 23.79% |
| CAGR/Max DD | 2.10 |
EPS (Earnings per Share)
Revenue
Description: SBS Companhia de Saneamento March 03, 2026
Companhia de Saneamento Básico do Estado de São Paulo (SABESP) is a major Brazilian utility provider specializing in water supply and sewage collection across 375 municipalities in São Paulo State. The company operates a regulated business model where revenue is generated through long-term concession agreements and wholesale service contracts. Headquartered in São Paulo, the firm manages millions of individual connections, providing critical infrastructure to one of South Americas most densely populated regions.
The water utility sector typically benefits from high barriers to entry and inelastic demand, as these services are essential for public health and urban development. SABESP’s operations are subject to regional regulatory frameworks that determine tariff adjustments based on operational costs and capital expenditure requirements. For a deeper look into the companys valuation metrics, consider reviewing the latest data on ValueRay.
Headlines to watch out for
- Water and sewage connection growth drives revenue
- Tariff adjustments impact profitability
- Drought conditions threaten water supply and operations
- Brazilian economic stability affects consumer affordability
- Regulatory changes to sanitation framework create uncertainty
Piotroski VR‑10 (Strict, 0-10) 3.5
| Net Income: 8.30b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA -1.60 > 1.0 |
| NWC/Revenue: 5.36% < 20% (prev -3.19%; Δ 8.56% < -1%) |
| CFO/TA 0.08 > 3% & CFO 8.36b > Net Income 8.30b |
| Net Debt (35.32b) to EBITDA (14.20b): 2.49 < 3 |
| Current Ratio: 1.12 > 1.5 & < 3 |
| Outstanding Shares: last quarter (684.2m) vs 12m ago 0.11% < -2% |
| Gross Margin: 36.64% > 18% (prev 0.49%; Δ 3.62k% > 0.5%) |
| Asset Turnover: 39.90% > 50% (prev 52.75%; Δ -12.84% > 0%) |
| Interest Coverage Ratio: 2.86 > 6 (EBITDA TTM 14.20b / Interest Expense TTM 4.21b) |
Altman Z'' 2.25
| A: 0.02 (Total Current Assets 18.55b - Total Current Liabilities 16.54b) / Total Assets 106.22b |
| B: 0.17 (Retained Earnings 18.25b / Total Assets 106.22b) |
| C: 0.13 (EBIT TTM 12.04b / Avg Total Assets 93.59b) |
| D: 0.67 (Book Value of Equity 42.85b / Total Liabilities 63.84b) |
| Altman-Z'' Score: 2.25 = BBB |
Beneish M -2.55
| DSRI: 1.36 (Receivables 5.98b/5.01b, Revenue 37.34b/42.71b) |
| GMI: 1.33 (GM 36.64% / 48.63%) |
| AQI: 0.95 (AQ_t 0.82 / AQ_t-1 0.86) |
| SGI: 0.87 (Revenue 37.34b / 42.71b) |
| TATA: -0.00 (NI 8.30b - CFO 8.36b) / TA 106.22b) |
| Beneish M-Score: -2.55 (Cap -4..+1) = A |
What is the price of SBS shares?
As of March 25, 2026, the stock is trading at USD 29.10 with a total of 1,098,389 shares traded.
Over the past week, the price has changed by +1.18%, over one month by -2.45%, over three months by +17.19% and over the past year by +78.09%.
Over the past week, the price has changed by +1.18%, over one month by -2.45%, over three months by +17.19% and over the past year by +78.09%.
Is SBS a buy, sell or hold?
Companhia de Saneamento has received a consensus analysts rating of 4.50.
Therefore, it is recommended to buy SBS.
- StrongBuy: 3
- Buy: 3
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the SBS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 31.6 | 8.7% |
| Analysts Target Price | 31.6 | 8.7% |
SBS Fundamental Data Overview March 22, 2026
Market Cap BRL = 108.18b (20.36b USD * 5.3141 USD.BRL)
P/E Trailing = 11.8723
P/E Forward = 15.7233
P/S = 0.5344
P/B = 2.4337
P/EG = 0.4697
Revenue TTM = 37.34b BRL
EBIT TTM = 12.04b BRL
EBITDA TTM = 14.20b BRL
Long Term Debt = 34.93b BRL (from longTermDebt, last quarter)
Short Term Debt = 4.96b BRL (from shortTermDebt, last quarter)
Debt = 39.99b BRL (from shortLongTermDebtTotal, last quarter)
Net Debt = 35.32b BRL (from netDebt column, last quarter)
Enterprise Value = 135.80b BRL (108.18b + Debt 39.99b - CCE 12.37b)
Interest Coverage Ratio = 2.86 (Ebit TTM 12.04b / Interest Expense TTM 4.21b)
EV/FCF = 17.13x (Enterprise Value 135.80b / FCF TTM 7.93b)
FCF Yield = 5.84% (FCF TTM 7.93b / Enterprise Value 135.80b)
FCF Margin = 21.23% (FCF TTM 7.93b / Revenue TTM 37.34b)
Net Margin = 22.21% (Net Income TTM 8.30b / Revenue TTM 37.34b)
Gross Margin = 36.64% ((Revenue TTM 37.34b - Cost of Revenue TTM 23.66b) / Revenue TTM)
Gross Margin QoQ = 32.46% (prev 31.77%)
Tobins Q-Ratio = 1.28 (Enterprise Value 135.80b / Total Assets 106.22b)
Interest Expense / Debt = 8.17% (Interest Expense 3.27b / Debt 39.99b)
Taxrate = 8.47% (233.1m / 2.75b)
NOPAT = 11.02b (EBIT 12.04b * (1 - 8.47%))
Current Ratio = 1.12 (Total Current Assets 18.55b / Total Current Liabilities 16.54b)
Debt / Equity = 0.94 (Debt 39.99b / totalStockholderEquity, last quarter 42.38b)
Debt / EBITDA = 2.49 (Net Debt 35.32b / EBITDA 14.20b)
Debt / FCF = 4.46 (Net Debt 35.32b / FCF TTM 7.93b)
Total Stockholder Equity = 40.98b (last 4 quarters mean from totalStockholderEquity)
RoA = 8.86% (Net Income 8.30b / Total Assets 106.22b)
RoE = 20.24% (Net Income TTM 8.30b / Total Stockholder Equity 40.98b)
RoCE = 15.85% (EBIT 12.04b / Capital Employed (Equity 40.98b + L.T.Debt 34.93b))
RoIC = 14.32% (NOPAT 11.02b / Invested Capital 76.92b)
WACC = 8.00% (E(108.18b)/V(148.17b) * Re(8.19%) + D(39.99b)/V(148.17b) * Rd(8.17%) * (1-Tc(0.08)))
Discount Rate = 8.19% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -81.65 | Cagr: -1.43%
[DCF] Terminal Value 81.60% ; FCFF base≈7.69b ; Y1≈9.49b ; Y5≈16.19b
[DCF] Fair Price = 346.0 (EV 278.39b - Net Debt 35.32b = Equity 243.07b / Shares 702.5m; r=8.00% [WACC]; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: -52.88 | EPS CAGR: -23.34% | SUE: 0.14 | # QB: 0
Revenue Correlation: 79.32 | Revenue CAGR: 22.82% | SUE: 3.67 | # QB: 2
EPS next Quarter (2026-06-30): EPS=0.46 | Chg7d=+0.028 | Chg30d=+0.028 | Revisions Net=-1 | Analysts=1
EPS current Year (2026-12-31): EPS=1.88 | Chg7d=-0.015 | Chg30d=-0.015 | Revisions Net=+2 | Growth EPS=+7.3% | Growth Revenue=+13.0%
EPS next Year (2027-12-31): EPS=3.04 | Chg7d=+0.150 | Chg30d=+0.150 | Revisions Net=+1 | Growth EPS=+60.7% | Growth Revenue=+17.4%
P/E Trailing = 11.8723
P/E Forward = 15.7233
P/S = 0.5344
P/B = 2.4337
P/EG = 0.4697
Revenue TTM = 37.34b BRL
EBIT TTM = 12.04b BRL
EBITDA TTM = 14.20b BRL
Long Term Debt = 34.93b BRL (from longTermDebt, last quarter)
Short Term Debt = 4.96b BRL (from shortTermDebt, last quarter)
Debt = 39.99b BRL (from shortLongTermDebtTotal, last quarter)
Net Debt = 35.32b BRL (from netDebt column, last quarter)
Enterprise Value = 135.80b BRL (108.18b + Debt 39.99b - CCE 12.37b)
Interest Coverage Ratio = 2.86 (Ebit TTM 12.04b / Interest Expense TTM 4.21b)
EV/FCF = 17.13x (Enterprise Value 135.80b / FCF TTM 7.93b)
FCF Yield = 5.84% (FCF TTM 7.93b / Enterprise Value 135.80b)
FCF Margin = 21.23% (FCF TTM 7.93b / Revenue TTM 37.34b)
Net Margin = 22.21% (Net Income TTM 8.30b / Revenue TTM 37.34b)
Gross Margin = 36.64% ((Revenue TTM 37.34b - Cost of Revenue TTM 23.66b) / Revenue TTM)
Gross Margin QoQ = 32.46% (prev 31.77%)
Tobins Q-Ratio = 1.28 (Enterprise Value 135.80b / Total Assets 106.22b)
Interest Expense / Debt = 8.17% (Interest Expense 3.27b / Debt 39.99b)
Taxrate = 8.47% (233.1m / 2.75b)
NOPAT = 11.02b (EBIT 12.04b * (1 - 8.47%))
Current Ratio = 1.12 (Total Current Assets 18.55b / Total Current Liabilities 16.54b)
Debt / Equity = 0.94 (Debt 39.99b / totalStockholderEquity, last quarter 42.38b)
Debt / EBITDA = 2.49 (Net Debt 35.32b / EBITDA 14.20b)
Debt / FCF = 4.46 (Net Debt 35.32b / FCF TTM 7.93b)
Total Stockholder Equity = 40.98b (last 4 quarters mean from totalStockholderEquity)
RoA = 8.86% (Net Income 8.30b / Total Assets 106.22b)
RoE = 20.24% (Net Income TTM 8.30b / Total Stockholder Equity 40.98b)
RoCE = 15.85% (EBIT 12.04b / Capital Employed (Equity 40.98b + L.T.Debt 34.93b))
RoIC = 14.32% (NOPAT 11.02b / Invested Capital 76.92b)
WACC = 8.00% (E(108.18b)/V(148.17b) * Re(8.19%) + D(39.99b)/V(148.17b) * Rd(8.17%) * (1-Tc(0.08)))
Discount Rate = 8.19% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -81.65 | Cagr: -1.43%
[DCF] Terminal Value 81.60% ; FCFF base≈7.69b ; Y1≈9.49b ; Y5≈16.19b
[DCF] Fair Price = 346.0 (EV 278.39b - Net Debt 35.32b = Equity 243.07b / Shares 702.5m; r=8.00% [WACC]; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: -52.88 | EPS CAGR: -23.34% | SUE: 0.14 | # QB: 0
Revenue Correlation: 79.32 | Revenue CAGR: 22.82% | SUE: 3.67 | # QB: 2
EPS next Quarter (2026-06-30): EPS=0.46 | Chg7d=+0.028 | Chg30d=+0.028 | Revisions Net=-1 | Analysts=1
EPS current Year (2026-12-31): EPS=1.88 | Chg7d=-0.015 | Chg30d=-0.015 | Revisions Net=+2 | Growth EPS=+7.3% | Growth Revenue=+13.0%
EPS next Year (2027-12-31): EPS=3.04 | Chg7d=+0.150 | Chg30d=+0.150 | Revisions Net=+1 | Growth EPS=+60.7% | Growth Revenue=+17.4%